We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+7.15%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$22.3B
AUM Growth
+$851M
(+4%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
1,274
New
347
Increased
260
Reduced
248
Closed
334
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
Analog Devices
ADI
|
+$121M |
| 4 |
United Therapeutics
UTHR
|
+$105M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$97.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$238M |
| 2 |
DXC Technology
DXC
|
+$235M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 4 |
NXP Semiconductors
NXPI
|
+$158M |
| 5 |
Baidu
BIDU
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Healthcare | 19.74% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 7.27% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
CALL
AdvisorShares Pure US Cannabis ETF
MSOS
$862M
| $6M | 0.03% |
150,000
-450,000
| -75% | -$18.3M |
|
|
NBSE
577
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $5.99M | 0.03% |
+62,500
| New | +$6.9M |
|
578
ARS Pharmaceuticals
SPRY
$513M
| $5.96M | 0.03% |
192,996
-94,604
| -33% | -$3.03M |
|
579
Intuit
INTU
$86.4B
| $5.94M | 0.03% |
12,110
-32,590
| -73% | -$14.1M |
|
580
Colgate-Palmolive
CL
$73.1B
| $5.91M | 0.03% |
+72,694
| New | +$5.94M |
|
581
Weibo
WB
$2B
| $5.91M | 0.03% |
+112,400
| New | +$5.57M |
|
|
GNCA
582
DELISTED
Genocea Biosciences, Inc.
GNCA
| $5.85M | 0.03% |
+2,500,000
| New | +$6.03M |
|
583
Fulcrum Therapeutics
FULC
$239M
| $5.79M | 0.03% |
552,885
-22,361
| -4% | -$226K |
|
584
Outset Medical
OM
$86.8M
| $5.67M | 0.03% |
+7,560
| New | +$5.78M |
|
585
GCM Grosvenor
GCMG
$749M
| $5.65M | 0.03% |
542,100
+202,100
| +59% | +$2.39M |
|
586
EQT Corp
EQT
$33.2B
| $5.63M | 0.03% |
+252,677
| New | +$5.1M |
|
|
CMPS
587
Compass Pathways
CMPS
$1.53B
| $5.61M | 0.03% |
+147,000
| New | +$5.25M |
|
588
MACOM Technology Solutions
MTSI
$19.6B
| $5.58M | 0.03% |
87,000
+15,000
| +21% | +$871K |
|
589
Dillards
DDS
$9.23B
| $5.52M | 0.02% |
30,500
+10,100
| +50% | +$1.3M |
|
|
ZNGA
590
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $5.5M | 0.02% |
516,998
+216,573
| +72% | +$2.28M |
|
|
NEUE
591
DELISTED
NeueHealth
NEUE
| $5.49M | 0.02% |
+4,000
| New | +$5.48M |
|
592
Viatris
VTRS
$20.5B
| $5.44M | 0.02% |
380,400
-41,800
| -10% | -$605K |
|
593
Marvell Technology
MRVL
$172B
| $5.42M | 0.02% |
93,000
-73,100
| -44% | -$3.57M |
|
594
CALL
Cheesecake Factory
CAKE
$5.03B
| $5.42M | 0.02% |
+100,000
| New | +$5.78M |
|
595
Bruker
BRKR
$9.62B
| $5.38M | 0.02% |
+70,860
| New | +$4.95M |
|
596
Syndax Pharmaceuticals
SNDX
$1.68B
| $5.36M | 0.02% |
312,400
-634,400
| -67% | -$11.6M |
|
597
Dick's Sporting Goods
DKS
$17.5B
| $5.34M | 0.02% |
53,318
+4,875
| +10% | +$437K |
|
|
NXGN
598
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $5.34M | 0.02% |
+321,998
| New | +$5.77M |
|
599
Consolidated Edison
ED
$40.3B
| $5.34M | 0.02% |
+74,400
| New | +$5.71M |
|
600
Cracker Barrel
CBRL
$1.25B
| $5.32M | 0.02% |
35,855
-75,545
| -68% | -$12.2M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Point72 Asset Management held 1,274 positions worth $22.3B, up 4% from $21.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Point72 Asset Management's Q2 2021 filing shows 347 new, 260 increased, 248 reduced and 334 closed positions. Its largest new stake was United Therapeutics: 552,400 shares worth $99.1M. The largest sale was Applied Materials, an estimated $238M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Point72 Asset Management's largest Q2 2021 buy was United Therapeutics: 552,400 shares worth $99.1M.
- Point72 Asset Management added most to Salesforce in Q2 2021, an estimated $372M increase.
- Point72 Asset Management's biggest Q2 2021 reduction was Applied Materials, cutting an estimated $238M.
- Point72 Asset Management fully exited DXC Technology in Q2 2021, selling an estimated $235M.
- Point72 Asset Management's ten largest holdings make up 18% of its $22.3B portfolio in Q2 2021.
- Point72 Asset Management opened 347 new positions and closed 334 in Q2 2021.
- Point72 Asset Management's portfolio value rose 4% quarter-over-quarter to $22.3B.
Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.